Most Marijuana Consumers Don't Believe Trump Administration Will Complete Rescheduling This Year, Poll Shows
Legal cannabis advocates face skepticism as DEA hearings clash with public expectations
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The Trump administration’s push to reschedule marijuana under federal law is under scrutiny amid conflicting signals. A DEA scientist testified against the agency’s own stance in court, while hearings on rescheduling proceed—but critics argue classification changes alone won’t address broader legalization barriers.
Circuit case testing the DEA’s authority. *The Hill* and *Marijuana Moment* emphasize the hearings’ symbolic nature, noting rescheduling won’t resolve banking or interstate commerce issues. Watch for court rulings on the DEA’s rescheduling process and whether the administration’s timeline aligns with congressional or state-level cannabis reforms.
Legal outcomes could redefine federal enforcement priorities, but public perception may dictate broader policy shifts.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (63% supported) Updated just now.
Quick answers
What is the DEA’s current stance on rescheduling marijuana?
The DEA has proposed rescheduling cannabis from Schedule I to Schedule III, but a DEA scientist testified in court against the agency’s own position, creating legal uncertainty.
Why do consumers doubt rescheduling will happen this year?
A poll cited by *Marijuana Moment* shows skepticism due to delays in the process, political gridlock, and the perception that rescheduling alone won’t resolve key issues like banking access or interstate sales.
What legal challenges are pending?
A D.C. Circuit case is examining the DEA’s authority to reschedule marijuana, with hearings underway but no final ruling yet.
Coverage (5)
- DEA Scientist Testifies Against DEA's Own Rescheduling Posture In Court The Globe and Mail · 21h ago
- Marijuana rescheduling hearings are finally here, but rescheduling is not enough The Hill · 21h ago
- Inside DEA’s cannabis rescheduling hearing (Newsletter: July 6, 2026) Marijuana Moment · 21h ago
- D.C. Circuit challenge and DEA hearing put federal cannabis rescheduling to the test Reuters · 21h ago
- Most Marijuana Consumers Don't Believe Trump Administration Will Complete Rescheduling This Year, Poll Shows Marijuana Moment · 21h ago
Topics
Related trends
NCGA: U.S. Farmers Paying Double for Some Crop Protection Products Compared to Brazil
U.S. farmers face a pricing gap with Brazil—some crop protection costs are twice as high, sparking calls for transparency
Apple Loses in EU Court on 'Gatekeeper' Regulations
Former executive accuses Mayo of cutting corners on AI research
Former Mayo Clinic executive files lawsuit alleging AI research shortcuts and retaliation
The Iran war has pushed some countries away from oil and toward clean energy
Iran war accelerates global shift from oil dependency as energy markets recalibrate
CAA Calls Out Meta For Making Its Muse AI Video and Photo Tool Opt-Out
SpaceX and AI startup wealth fuels demand for private jets
A surge in private jet demand is being linked to wealth generation from the AI and aerospace sectors, according to recent business reports.